Clinical Trial Update: GIS-SUSANTI-TNF-2015 (Anti-TNF Discontinuation ) [Phase 4]

View source ↗

Summary

Phase 4 trial update for an anti-TNF discontinuation strategy in Crohn's disease and inflammatory bowel disease (including ulcerative colitis).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Inflammatory Bowel Disease
• Ulcerative Colitis

Drugs mentioned

• GIS-SUSANTI-TNF (null)

Snippet

Sponsor: Fundación de Investigación Biomédica - Hospital Universitario de La Princesa | Conditions: Crohn's Disease, Inflammatory Bowel Disease | Phase 4 | Status: COMPLETED